Data Composite

Drug Recalls

Recent drug recall reports from the FDA (US) and Health Canada, newest first. Each entry links to the full record -- product description, reason for recall, and severity classification -- refreshed daily.

Charac-50 (2017-01-13)

Canada Type II Archived · initiated 2017-02-27

Product safety

Teva-Lorazepam 0.5 mg (2017-02-09)

Canada Type III Archived · initiated 2017-02-23

Product safety

Enerforce Total (2017-02-09)

Canada Type II Archived · initiated 2017-02-22

Product safety

Teva-Lorazepam 1 mg (2017-02-09)

Canada Type III Archived · initiated 2017-02-22

Product safety

Lorazepam 0.5 mg (2017-02-09)

Canada Type III Archived · initiated 2017-02-22

Product safety

The Root Of Life Ultra Enerforce Ampoules (2017-02-09)

Canada Type II Archived · initiated 2017-02-22

Product safety

18 F- Fluorodeoxyglucose (2017-01-30)

Canada Type III Archived · initiated 2017-02-22

Product safety

Lorazepam 1 mg (2017-02-09)

Canada Type III Archived · initiated 2017-02-22

Product safety

Tc-MDP-21 (2017-01-30)

Canada Type III Archived · initiated 2017-02-22

Product safety

18 F- Fluorodeoxyglucose (2017-01-24)

Canada Type III Archived · initiated 2017-02-22

Product safety

PMS-Propofol (2017-02-17)

Canada Type I Archived · initiated 2017-02-21

Product safety

B&B Toothpaste for Children

Canada Type III Archived · initiated 2017-02-08

Product safety

AOR-MCP (2016-01-23)

Canada Type II Archived · initiated 2017-02-08

Product safety

Recall of Cannabis for Medical Purposes - Mettrum Ltd.

Canada Type III Archived · initiated 2017-02-07

Undeclared substance

Cloxacillin Sodium 2000 mg for injection (2017-01-27)

Canada Type III Archived · initiated 2017-02-03

Product safety

Cloxacillin Sodium 1000 mg for injection (2017-01-27)

Canada Type III Archived · initiated 2017-02-03

Product safety

Cloxacillin Sodium 500 mg for injection (2017-01-27)

Canada Type III Archived · initiated 2017-02-03

Product safety

Riva-Citalopram

Canada Type II Archived · initiated 2017-01-30

Product safety

Charac-25 (2017-01-13)

Canada Type II Archived · initiated 2017-01-27

Medical devices

Charactol-50 (2017-01-13)

Canada Type II Archived · initiated 2017-01-27

Product safety

Charactol-25 (2017-01-13)

Canada Type II Archived · initiated 2017-01-27

Medical devices

Octagam (2017-01-16)

Canada Type II Archived · initiated 2017-01-25

Product safety

Sertraline (2017-01-11)

Canada Type III Archived · initiated 2017-01-17

Product safety

Apo-Sertraline (2017-01-13)

Canada Type III Archived · initiated 2017-01-16

Product safety

Recall of Cannabis for Medical Purposes - Aurora Cannabis Enterprises Inc.

Canada Type II Archived · initiated 2017-01-13

Undeclared substance